COVID-19 (Coronavirus)

Recruiting

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)

J2W-MC-PYAB - ClinicalTrials.gov - NCT04427501

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.
How long will I be in the trial?
Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.
Email
Recruiting

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)

J2W-MC-PYAB - ClinicalTrials.gov - NCT04427501

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.
How long will I be in the trial?
Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must test positive for COVID-19 within three days before starting the study

Participants must have mild to moderate COVID-19 illness

Participants must have at least one of the following: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, or shortness of breath when active

Participants must NOT

Participants must not be in the hospital

Participants must not need a machine to help them breathe (ventilator)

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

LY3819253, LY-CoV555, LY3832479, LY-CoV016

Could I receive a Placebo?

yes

Enrollment Goal

800

Trial Dates

June 2020 - January 2021

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must test positive for COVID-19 within three days before starting the study

Participants must have mild to moderate COVID-19 illness

Participants must have at least one of the following: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, or shortness of breath when active

Participants must NOT

Participants must not be in the hospital

Participants must not need a machine to help them breathe (ventilator)

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

LY3819253, LY-CoV555, LY3832479, LY-CoV016

Could I receive a Placebo?

yes

Enrollment Goal

800

Trial Dates

June 2020 - January 2021

Trial Phase

2

Not the right fit? Sign up to receive updates on new COVID-19 (Coronavirus) trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

COVID-19 (Coronavirus) Resources

COVID-19

Lilly's COVID-19 Clinical Trials are Underway

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.
COVID-19

Types of Clinical Research for COVID-19

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.
COVID-19 teams chat

COVID-19 Research

COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?